Monday, February 2, 2026

GOLD ALERT

Dear Reader,

Gold has shattered records, soaring past $3,800 an ounce...

But Stansberry Senior Partner Dr. David "Doc" Eifrig says history shows it could be on the verge of its biggest bull run in over half a century.

His research shows it could be triggered by a major event, eerily similar to what happened in the 1970s.

It's NOT inflation, fed rate cut expectations, escalating geopolitical tensions, or anything you're likely expecting.

And Doc believes you MUST own shares of his top gold stock.

He says you could 10x your money without touching a risky miner or a boring exchange-traded fund.

Get all the facts here.

It's the centerpiece of Doc's full gameplan for this wild market, with extraordinary upside potential.

Click here for the full details on this developing gold story.

Regards,

Matt Weinschenk
Director of Research, Stansberry Research


 
 
 
 
 
 

Additional Reading from MarketBeat Media

Procter & Gamble Confirms a Bottom—Time to Start Compounding?

Author: Thomas Hughes. Article Posted: 1/25/2026.

Tide detergent and Dawn dish soap on kitchen counter, highlighting Procter & Gamble consumer staples stock.

What You Need to Know

  • Procter & Gamble’s stock appears to have bottomed in early 2026, trading at long-term lows with a resilient business capable of sustaining dividends and capital returns.
  • As a Dividend King, PG offers a nearly 3% yield backed by nearly 70 years of distribution increases and a healthy balance sheet.
  • Recent earnings and share buybacks support a rebound thesis, with analysts reverting to a more bullish stance and institutional ownership rising.

Procter & Gamble (NYSE: PG) confirmed a bottom in early 2026, and its stock is positioned to advance meaningfully over the coming years.

With the stock trading near long-term lows, the market had largely priced in a worst-case scenario — tepid growth. Yet even modest growth is sufficient to preserve the company's financial health and its ability to pay dividends, which is an important consideration for many investors.

The day the gold market broke (Ad)

On September 14th, 2023, something big happened that didn't make the news. The price gap between London gold and Shanghai gold blew out to $120 an ounce. For years, that gap was a few dollars, maybe $5 or $10. A 20x jump in seconds isn't a glitch, it's the system breaking. Traders tried to buy gold in London to sell in Shanghai, but hit a wall. The London vaults were empty. Since that day, gold has hit 53 all-time highs. One stock is positioned to capture the bulk of this wealth transfer.

See the full story on this opportunity now.tc pixel

PG shares are near the low end of their historical valuation range and currently yield roughly 2.9%, above the market average.

That's a relatively secure 2.9% yield with an expectation of distribution growth: Procter & Gamble is a Dividend King, having raised its payout for nearly 70 years.

Procter & Gamble (PG) stock chart shows bottoming near support as EMAs, stochastics and MACD improve.

Dividend Aristocrats and Kings have long track records of paying and increasing distributions. While dividends aren't indestructible, they are supported by blue-chip businesses, reliable cash flow, and healthy balance sheets that can withstand downturns and continue capital returns.

Dividends matter to buy-and-hold compounders because reinvestment compounds returns and magnifies distribution growth. Procter & Gamble maintains a relatively low payout ratio for a company with such a long track record and has delivered mid-single-digit compound annual growth in its distributions as of early 2026. The current opportunity for investors is to build positions over time, using levels such as the recent price floor near $140 and commonly used technical triggers — moving averages and prior support/resistance — to add.

Procter & Gamble Triggers Rebound With FQ2 Release

Procter & Gamble's Q2 fiscal 2026 (FY2026) earnings weren't spectacular but showed a resilient consumer staples business capable of sustaining its health and capital returns. Reported revenue grew about 1%, influenced by foreign exchange; core results reflected roughly a 1% decline in volume offset by about 1% pricing. Beauty and Healthcare were the best-performing segments, each up about 5%, while most other segments saw modest growth. Baby, Feminine & Family Care declined 3% amid tough year-ago comparisons, when pantry-loading occurred ahead of a potential port strike.

Margins and guidance were acceptable. Adjusted EPS declined about 2% after FX, but at $1.88 they topped expectations despite the soft top line, which is enough to sustain the capital return outlook. Management reaffirmed full-year growth and earnings guidance, calling for a midpoint of $6.96 — in line with analyst consensus.

Procter & Gamble Share Buybacks Provide Leverage for Investors

Free cash flow supports both dividends and share repurchases, increasing the potential for a meaningful rebound in the stock over time. Q2 FY2026 buyback activity reduced the share count by roughly 1.4% year-to-date, and management expects repurchases to continue at a healthy pace. The balance sheet remains solid, with increased cash and total assets, a 2% rise in equity, and relatively low leverage (long-term debt about 0.5x equity).

Analysts and institutional flows also support the rebound. Although many analysts trimmed price targets in 2025, they continue to rate the stock a Moderate Buy and have adopted a more bullish posture in early 2026. Consensus sees roughly 10% upside from a key resistance area near a major moving average. Institutions — which own more than 65% of the shares — accumulated throughout 2025 and extended buying into the first weeks of 2026, reinforcing the recovery case.


 
Thank you for subscribing to The Early Bird, MarketBeat's 7:00 AM newsletter that covers stories that will impact the stock market each day.
 
This email message is a paid advertisement from Stansberry Research, a third-party advertiser of The Early Bird and MarketBeat.
 
 

This ad is sent on behalf of Stansberry Research, 1125 N Charles St, Baltimore, MD 21201. If you would like to optout from receiving offers from Stansberry Research please click here.


 
 
If you have questions or concerns about your subscription, don't hesitate to email MarketBeat's U.S. based support team at contact@marketbeat.com.
 
If you no longer wish to receive email from The Early Bird, you can unsubscribe.
 
Copyright 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States..
 
Daily Bonus Content: REVEALED: Something Big Happening Behind White House Doors (From Paradigm Press)

No comments:

Page List

Blog Archive

Search This Blog

U.S. v. Columbus McKinnon Corporation, et al.

You are subscribed to Antitrust Civil Case Filings for U.S. Department of Justice. This information has recent...